Download presentation
Presentation is loading. Please wait.
Published byAllen Carr Modified over 9 years ago
1
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 40 Antiviral Drugs
2
2 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Understanding Viruses Viral replication A virus cannot replicate on its own It must attach to and enter a host cell It then uses the host cell’s energy to synthesize protein, DNA, and RNA
3
3 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
4
4 Understanding Viruses (cont’d) Viruses are difficult to kill because they live inside the cells Any drug that kills a virus may also kill cells
5
5 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Viral Illnesses Most viral illnesses are bothersome, but survivable Effective vaccines have prevented some illnesses Effective drug therapy is available for a small number of viral infections
6
6 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Antiviral Drugs Antiviral drugs kill or suppress the virus by destroying virions or inhibiting ability to replicate viruses controlled by current antiviral therapy
7
7 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Antiviral Drugs (cont’d) Viruses controlled by current antiviral therapy Cytomegalovirus (CMV) Hepatitis viruses Herpes viruses Human immunodeficiency virus (HIV) Influenza viruses (the “flu”) Respiratory syncytial virus (RSV)
8
8 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Antiviral Drugs (cont’d) Key characteristics of antiviral drugs Able to enter the cells infected with virus Interfere with viral nucleic acid synthesis and/or regulation Some drugs interfere with ability of virus to bind to cells Some drugs stimulate the body’s immune system
9
9 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Antiviral Drugs (cont’d) Best responses to antiviral drugs are in patients with competent immune systems A healthy immune system works synergistically with the drug to eliminate or suppress viral activity
10
10 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Antiviral Drugs (cont’d) Opportunistic infections Occur in immunocompromised patients Would not normally harm an immunocompetent person Require long-term prophylaxis and antiinfective drug therapy Can be other viruses, fungi, bacteria, or protozoa
11
11 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Antiviral Drugs (cont’d) Antiviral drugs Used to treat infections caused by viruses other than HIV Antiretroviral drugs Used to treat infections caused by HIV, the virus that causes AIDS
12
12 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Virus Infections Herpes-simplex viruses HSV-1 (oral herpes) HSV-2 (genital herpes) Human herpesvirus/VZV Chickenpox and shingles (HHV-3 or VZV) Epstein-Barr (HHV-4) Cytomegalovirus (HHV-5) Kaposi’s sarcoma (HHV-8)
13
13 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Antiviral Drugs (non-HIV) Mechanism of action Inhibit viral replication Used to treat non-HIV viral infections Influenza viruses HSV, VZV CMV Hepatitis A, B, C (HAV, HBV, HCV)
14
14 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Antiviral Drugs (non-HIV) (cont’d) Adverse effects Vary with each drug Healthy cells are often killed also, resulting in serious toxicities
15
15 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Antiviral Drugs (non-HIV) (cont’d) amantadine (Symmetrel) Narrow antiviral spectrum; active only against influenza A 2008 CDC guidelines do not recommend use for treatment or prevention of flu CNS effects: insomnia, nervousness, lightheadedness GI effects: anorexia, nausea, others
16
16 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Antiviral Drugs (non-HIV) (cont’d) rimantadine (Flumadine) Same spectrum of activity, mechanism of action, and indications as amantadine Fewer CNS adverse effects Causes GI upset
17
17 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Antiviral Drugs (non-HIV) (cont’d) acyclovir (Zovirax) Synthetic nucleoside analog Used to suppress replication of: HSV-1, HSV-2, VZV HSV-1, HSV-2, VZV Drug of choice for treatment of initial and recurrent episodes of these infections Oral, topical, parenteral forms
18
18 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Antiviral Drugs (non-HIV) (cont’d) ganciclovir (Cytovene) Synthetic nucleoside analog Used to treat infection with cytomegalovirus (CMV) Oral, parenteral forms CMV retinitis Ophthalmic form surgically implanted Ophthalmic form surgically implanted Ocular injection (fomivirsen) Ocular injection (fomivirsen)
19
19 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Antiviral Drugs (non-HIV): Dose-Limiting Toxicities ganciclovir Bone marrow toxicity foscarnet and cidofovir Renal toxicity
20
20 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Antiviral Drugs (non-HIV): Neuraminidase Inhibitors oseltamivir (Tamiflu) and zanamivir (Relenza) Active against influenza types A and B Reduce duration of illness Oseltamivir: causes nausea and vomiting Zanamivir: causes diarrhea, nausea, sinusitis Treatment should begin within 2 days of influenza symptom onset
21
21 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Antiviral Drugs (non-HIV): Ribavirin Synthetic nucleoside analog Given orally, or oral or nasal inhalation Inhalation form (Virazole) used for hospitalized infants with RSV infections
22
22 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
23
23
24
24
25
25 HIV and AIDS Human immunodeficiency virus (HIV) infection and acquired immune deficiency syndrome (AIDS) ELISA (enzyme-linked immunosorbent assay) Detects HIV exposure based on presence of human antibodies to the virus in the blood Detects HIV exposure based on presence of human antibodies to the virus in the blood Retrovirus Transmitted by sexual activity, intravenous drug use, perinatally from mother to child
26
26 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Four Stages of HIV Infection* Stage 1: asymptomatic infection Stage 2: early, general symptoms of disease Stage 3: moderate symptoms Stage 4: severe symptoms, often leading to death *WHO model
27
27 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Opportunistic Infections Protozoal Toxoplasmosis of the brain, others Fungal Candidiasis of the lungs, esophagus, trachea Pneumocystis jirovecii pneumonia, others Viral CMV disease, HSV infection, others
28
28 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Opportunistic Infections (cont’d) Bacterial Various mycobacterial infections, others Extrapulmonary TB Opportunistic neoplasias Kaposi’s sarcoma, others HIV wasting syndrome Major weight loss, chronic diarrhea, chronic fever
29
29 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Antiretroviral Drugs HAART Highly active antiretroviral therapy Includes at least three medications “Cocktails” These medications work in different ways to reduce the viral load
30
30 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Antiretroviral Drugs (cont’d) Reverse transcriptase inhibitors (RTIs) Block activity of the enzyme reverse transcriptase, preventing production of new viral DNA Protease inhibitors (PIs) Inhibit the protease retroviral enzyme, preventing viral replication Fusion inhibitors Inhibit viral fusion, preventing viral replication Entry inhibitor-CCR5 coreceptor antagonists HIV integrase strand transfer inhibitors
31
31 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Antiretroviral Drugs (cont’d) Reverse transcriptase inhibitors (RTIs) Nucleoside RTIs (NRTIs) Nonnucleoside RTIs (NNRTIs) Examples abacavir (Ziagen) delavirdine (Rescriptor) didanosine (Videx) lefavirenze Sustiva) stavudine (Zerit) etavirine (Intelence) tenofovir (Viread) didanosine (Videx)
32
32 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Antiretroviral Drugs (cont’d) zidovudine (Retrovir) First anti-HIV medication Nucleoside reverse transcriptase inhibitor Can be given to pregnant HIV-positive women and newborn babies to prevent maternal transmission of HIV Major dose-limiting adverse effect: bone marrow suppression
33
33 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Antiretroviral Drugs (cont’d) Protease inhibitors (PIs) Inhibit the protease retroviral enzyme, preventing viral replication amprenavir (Agenerase) indinavir (Crixivan) nelfinavir (Viracept) ritonavir (Norvir)
34
34 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Antiretroviral Drugs (cont’d) Fusion inhibitors Inhibit viral fusion, preventing viral replication A newer class of antiretroviral drugs Example: enfuvirtide (Fuzeon)
35
35 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Antiretroviral Drugs (cont’d) CCR5 antagonist maraviroc (Selzentry) HIV integrase strand transfer inhibitor raltegravir (Isentress)
36
36 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Antiretroviral Drugs (cont’d) Combinations of multiple antiretroviral medications are common Adverse effects vary with each drug and may be severe; monitor for dose-limiting toxicities Monitor for signs of opportunistic diseases
37
37 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Antiretroviral Drugs: Adverse Effects Numerous and vary with each drug Drug therapy may need to be modified because of adverse effects Goal is to find the regimen that will best control the infection with a tolerable adverse effect profile Medication regimens change during the course of the illness
38
38 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Nursing Implications Before beginning therapy, thoroughly assess underlying disease and medical history, including allergies Assess baseline vital signs and nutritional status Assess for contraindications, conditions that may indicate cautious use, and potential drug interactions
39
39 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Nursing Implications (cont’d) Be sure to teach proper application technique for ointments, aerosol powders, and so on Emphasize hand washing before and after administration of medications to prevent site contamination and spread of infection Instruct patients to wear a glove or finger cot when applying ointments or solutions to affected areas
40
40 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Nursing Implications (cont’d) Instruct patients to consult their physician before taking any other medication, including over-the-counter medications Emphasize the importance of good hygiene Inform patients that antiviral drugs are not cures but do help to manage symptoms
41
41 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Nursing Implications (cont’d) Instruct patients on the importance of taking these medications exactly as prescribed and for the full course of treatment Instruct patients to start therapy with antiviral drugs at the earliest sign of recurrent episodes of genital herpes or herpes zoster
42
42 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Nursing Implications (cont’d) Monitor for adverse effects Effects are varied and specific to each drug Monitor for therapeutic effects Effects will vary depending on the type of viral infection Effects range from delayed progression of AIDS and other viruses to decrease in flulike symptoms, decrease in frequency of herpes-like flare-ups, or crusting over of herpetic lesions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.